Loading…
Ketone metabolism in the failing heart
The high energy demands of the heart are met primarily by the mitochondrial oxidation of fatty acids and glucose. However, in heart failure there is a decrease in cardiac mitochondrial oxidative metabolism and glucose oxidation that can lead to an energy starved heart. Ketone bodies are readily oxid...
Saved in:
Published in: | Biochimica et biophysica acta. Molecular and cell biology of lipids 2020-12, Vol.1865 (12), p.158813-158813, Article 158813 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643 |
---|---|
cites | cdi_FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643 |
container_end_page | 158813 |
container_issue | 12 |
container_start_page | 158813 |
container_title | Biochimica et biophysica acta. Molecular and cell biology of lipids |
container_volume | 1865 |
creator | Lopaschuk, Gary D. Karwi, Qutuba G. Ho, Kim L. Pherwani, Simran Ketema, Ezra B. |
description | The high energy demands of the heart are met primarily by the mitochondrial oxidation of fatty acids and glucose. However, in heart failure there is a decrease in cardiac mitochondrial oxidative metabolism and glucose oxidation that can lead to an energy starved heart. Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart. Ketone oxidation is increased in the failing heart, which may be an adaptive response to lessen the severity of heart failure. While ketone have been widely touted as a “thrifty fuel”, increasing ketone oxidation in the heart does not increase cardiac efficiency (cardiac work/oxygen consumed), but rather does provide an additional fuel source for the failing heart. Increasing ketone supply to the heart and increasing mitochondrial ketone oxidation increases mitochondrial tricarboxylic acid cycle activity. In support of this, increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients. Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart. While ketogenic diets increase circulating ketone levels, minimal benefit on cardiac function in heart failure has been observed, possibly due to the fact that these dietary regimens also markedly increase circulating fatty acids. Recent studies, however, have suggested that administration of ketone ester cocktails may improve cardiac function in heart failure. Combined, emerging data suggests that increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure.
•Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart.•Increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients.•Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart.•Ketone ester cocktails may improve cardiac function in heart failure.•Increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure. |
doi_str_mv | 10.1016/j.bbalip.2020.158813 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2442598180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1388198120302055</els_id><sourcerecordid>2442598180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643</originalsourceid><addsrcrecordid>eNp9kEtLBDEQhIMoPlb_gcicxMusnWSSSS6CLL5wwYueQybT42aZx5rMCv57s4x69NRNUdVNfYScU5hToPJ6Pa8q2_rNnAFLklCK8j1yTFWpcyap2k87VyqnWtEjchLjGoAKzsUhOeJMM6BcH5PLZxyHHrMOR1sNrY9d5vtsXGHWWN_6_j1boQ3jKTlobBvx7GfOyNv93eviMV--PDwtbpe545KNOWsqWZZOADintKplkq0uhGVSN1AWwBvkXAOgpbqq61IqLhwFK3SFVhZ8Rq6mu5swfGwxjqbz0WHb2h6HbTSsKJhIhRQkazFZXRhiDNiYTfCdDV-GgtkRMmszETI7QmYilGIXPx-2VYf1X-gXSTLcTAZMPT89BhOdx95h7QO60dSD___DN-lQdnc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2442598180</pqid></control><display><type>article</type><title>Ketone metabolism in the failing heart</title><source>ScienceDirect Journals</source><creator>Lopaschuk, Gary D. ; Karwi, Qutuba G. ; Ho, Kim L. ; Pherwani, Simran ; Ketema, Ezra B.</creator><creatorcontrib>Lopaschuk, Gary D. ; Karwi, Qutuba G. ; Ho, Kim L. ; Pherwani, Simran ; Ketema, Ezra B.</creatorcontrib><description>The high energy demands of the heart are met primarily by the mitochondrial oxidation of fatty acids and glucose. However, in heart failure there is a decrease in cardiac mitochondrial oxidative metabolism and glucose oxidation that can lead to an energy starved heart. Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart. Ketone oxidation is increased in the failing heart, which may be an adaptive response to lessen the severity of heart failure. While ketone have been widely touted as a “thrifty fuel”, increasing ketone oxidation in the heart does not increase cardiac efficiency (cardiac work/oxygen consumed), but rather does provide an additional fuel source for the failing heart. Increasing ketone supply to the heart and increasing mitochondrial ketone oxidation increases mitochondrial tricarboxylic acid cycle activity. In support of this, increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients. Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart. While ketogenic diets increase circulating ketone levels, minimal benefit on cardiac function in heart failure has been observed, possibly due to the fact that these dietary regimens also markedly increase circulating fatty acids. Recent studies, however, have suggested that administration of ketone ester cocktails may improve cardiac function in heart failure. Combined, emerging data suggests that increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure.
•Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart.•Increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients.•Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart.•Ketone ester cocktails may improve cardiac function in heart failure.•Increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure.</description><identifier>ISSN: 1388-1981</identifier><identifier>EISSN: 1879-2618</identifier><identifier>DOI: 10.1016/j.bbalip.2020.158813</identifier><identifier>PMID: 32920139</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Drug Discovery ; Energy Metabolism - drug effects ; Fatty acid oxidation ; Glucose - metabolism ; Glucose oxidation ; Heart - drug effects ; Heart - physiopathology ; Heart failure ; Heart Failure - drug therapy ; Heart Failure - metabolism ; Heart Failure - physiopathology ; Humans ; Ketone Bodies - metabolism ; Ketone body ; NLRP3 inflammasome ; Oxidation-Reduction - drug effects ; Sodium glucose co-transporter 2 inhibitors</subject><ispartof>Biochimica et biophysica acta. Molecular and cell biology of lipids, 2020-12, Vol.1865 (12), p.158813-158813, Article 158813</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643</citedby><cites>FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32920139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lopaschuk, Gary D.</creatorcontrib><creatorcontrib>Karwi, Qutuba G.</creatorcontrib><creatorcontrib>Ho, Kim L.</creatorcontrib><creatorcontrib>Pherwani, Simran</creatorcontrib><creatorcontrib>Ketema, Ezra B.</creatorcontrib><title>Ketone metabolism in the failing heart</title><title>Biochimica et biophysica acta. Molecular and cell biology of lipids</title><addtitle>Biochim Biophys Acta Mol Cell Biol Lipids</addtitle><description>The high energy demands of the heart are met primarily by the mitochondrial oxidation of fatty acids and glucose. However, in heart failure there is a decrease in cardiac mitochondrial oxidative metabolism and glucose oxidation that can lead to an energy starved heart. Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart. Ketone oxidation is increased in the failing heart, which may be an adaptive response to lessen the severity of heart failure. While ketone have been widely touted as a “thrifty fuel”, increasing ketone oxidation in the heart does not increase cardiac efficiency (cardiac work/oxygen consumed), but rather does provide an additional fuel source for the failing heart. Increasing ketone supply to the heart and increasing mitochondrial ketone oxidation increases mitochondrial tricarboxylic acid cycle activity. In support of this, increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients. Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart. While ketogenic diets increase circulating ketone levels, minimal benefit on cardiac function in heart failure has been observed, possibly due to the fact that these dietary regimens also markedly increase circulating fatty acids. Recent studies, however, have suggested that administration of ketone ester cocktails may improve cardiac function in heart failure. Combined, emerging data suggests that increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure.
•Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart.•Increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients.•Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart.•Ketone ester cocktails may improve cardiac function in heart failure.•Increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure.</description><subject>Animals</subject><subject>Drug Discovery</subject><subject>Energy Metabolism - drug effects</subject><subject>Fatty acid oxidation</subject><subject>Glucose - metabolism</subject><subject>Glucose oxidation</subject><subject>Heart - drug effects</subject><subject>Heart - physiopathology</subject><subject>Heart failure</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - metabolism</subject><subject>Heart Failure - physiopathology</subject><subject>Humans</subject><subject>Ketone Bodies - metabolism</subject><subject>Ketone body</subject><subject>NLRP3 inflammasome</subject><subject>Oxidation-Reduction - drug effects</subject><subject>Sodium glucose co-transporter 2 inhibitors</subject><issn>1388-1981</issn><issn>1879-2618</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLBDEQhIMoPlb_gcicxMusnWSSSS6CLL5wwYueQybT42aZx5rMCv57s4x69NRNUdVNfYScU5hToPJ6Pa8q2_rNnAFLklCK8j1yTFWpcyap2k87VyqnWtEjchLjGoAKzsUhOeJMM6BcH5PLZxyHHrMOR1sNrY9d5vtsXGHWWN_6_j1boQ3jKTlobBvx7GfOyNv93eviMV--PDwtbpe545KNOWsqWZZOADintKplkq0uhGVSN1AWwBvkXAOgpbqq61IqLhwFK3SFVhZ8Rq6mu5swfGwxjqbz0WHb2h6HbTSsKJhIhRQkazFZXRhiDNiYTfCdDV-GgtkRMmszETI7QmYilGIXPx-2VYf1X-gXSTLcTAZMPT89BhOdx95h7QO60dSD___DN-lQdnc</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Lopaschuk, Gary D.</creator><creator>Karwi, Qutuba G.</creator><creator>Ho, Kim L.</creator><creator>Pherwani, Simran</creator><creator>Ketema, Ezra B.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202012</creationdate><title>Ketone metabolism in the failing heart</title><author>Lopaschuk, Gary D. ; Karwi, Qutuba G. ; Ho, Kim L. ; Pherwani, Simran ; Ketema, Ezra B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Drug Discovery</topic><topic>Energy Metabolism - drug effects</topic><topic>Fatty acid oxidation</topic><topic>Glucose - metabolism</topic><topic>Glucose oxidation</topic><topic>Heart - drug effects</topic><topic>Heart - physiopathology</topic><topic>Heart failure</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - metabolism</topic><topic>Heart Failure - physiopathology</topic><topic>Humans</topic><topic>Ketone Bodies - metabolism</topic><topic>Ketone body</topic><topic>NLRP3 inflammasome</topic><topic>Oxidation-Reduction - drug effects</topic><topic>Sodium glucose co-transporter 2 inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lopaschuk, Gary D.</creatorcontrib><creatorcontrib>Karwi, Qutuba G.</creatorcontrib><creatorcontrib>Ho, Kim L.</creatorcontrib><creatorcontrib>Pherwani, Simran</creatorcontrib><creatorcontrib>Ketema, Ezra B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochimica et biophysica acta. Molecular and cell biology of lipids</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lopaschuk, Gary D.</au><au>Karwi, Qutuba G.</au><au>Ho, Kim L.</au><au>Pherwani, Simran</au><au>Ketema, Ezra B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ketone metabolism in the failing heart</atitle><jtitle>Biochimica et biophysica acta. Molecular and cell biology of lipids</jtitle><addtitle>Biochim Biophys Acta Mol Cell Biol Lipids</addtitle><date>2020-12</date><risdate>2020</risdate><volume>1865</volume><issue>12</issue><spage>158813</spage><epage>158813</epage><pages>158813-158813</pages><artnum>158813</artnum><issn>1388-1981</issn><eissn>1879-2618</eissn><abstract>The high energy demands of the heart are met primarily by the mitochondrial oxidation of fatty acids and glucose. However, in heart failure there is a decrease in cardiac mitochondrial oxidative metabolism and glucose oxidation that can lead to an energy starved heart. Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart. Ketone oxidation is increased in the failing heart, which may be an adaptive response to lessen the severity of heart failure. While ketone have been widely touted as a “thrifty fuel”, increasing ketone oxidation in the heart does not increase cardiac efficiency (cardiac work/oxygen consumed), but rather does provide an additional fuel source for the failing heart. Increasing ketone supply to the heart and increasing mitochondrial ketone oxidation increases mitochondrial tricarboxylic acid cycle activity. In support of this, increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients. Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart. While ketogenic diets increase circulating ketone levels, minimal benefit on cardiac function in heart failure has been observed, possibly due to the fact that these dietary regimens also markedly increase circulating fatty acids. Recent studies, however, have suggested that administration of ketone ester cocktails may improve cardiac function in heart failure. Combined, emerging data suggests that increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure.
•Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart.•Increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients.•Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart.•Ketone ester cocktails may improve cardiac function in heart failure.•Increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>32920139</pmid><doi>10.1016/j.bbalip.2020.158813</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1388-1981 |
ispartof | Biochimica et biophysica acta. Molecular and cell biology of lipids, 2020-12, Vol.1865 (12), p.158813-158813, Article 158813 |
issn | 1388-1981 1879-2618 |
language | eng |
recordid | cdi_proquest_miscellaneous_2442598180 |
source | ScienceDirect Journals |
subjects | Animals Drug Discovery Energy Metabolism - drug effects Fatty acid oxidation Glucose - metabolism Glucose oxidation Heart - drug effects Heart - physiopathology Heart failure Heart Failure - drug therapy Heart Failure - metabolism Heart Failure - physiopathology Humans Ketone Bodies - metabolism Ketone body NLRP3 inflammasome Oxidation-Reduction - drug effects Sodium glucose co-transporter 2 inhibitors |
title | Ketone metabolism in the failing heart |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A55%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ketone%20metabolism%20in%20the%20failing%20heart&rft.jtitle=Biochimica%20et%20biophysica%20acta.%20Molecular%20and%20cell%20biology%20of%20lipids&rft.au=Lopaschuk,%20Gary%20D.&rft.date=2020-12&rft.volume=1865&rft.issue=12&rft.spage=158813&rft.epage=158813&rft.pages=158813-158813&rft.artnum=158813&rft.issn=1388-1981&rft.eissn=1879-2618&rft_id=info:doi/10.1016/j.bbalip.2020.158813&rft_dat=%3Cproquest_cross%3E2442598180%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2442598180&rft_id=info:pmid/32920139&rfr_iscdi=true |